Cross Country Healthcare (CCRN) Upgraded to “Hold” at Zacks Investment Research
Zacks Investment Research upgraded shares of Cross Country Healthcare (NASDAQ:CCRN) from a sell rating to a hold rating in a report published on Tuesday morning.
According to Zacks, “Cross Country Healthcare, Inc. is a national leader in providing innovative healthcare workforce solutions and staffing services. Their diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. They are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. They are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services. “
A number of other equities analysts have also recently commented on the stock. ValuEngine cut shares of Cross Country Healthcare from a sell rating to a strong sell rating in a research note on Saturday, September 22nd. BidaskClub cut shares of Cross Country Healthcare from a buy rating to a hold rating in a research note on Thursday, September 13th. Credit Suisse Group cut their price target on shares of Cross Country Healthcare from $11.50 to $9.00 and set a neutral rating for the company in a research note on Thursday, August 2nd. Barrington Research set a $13.00 price objective on shares of Cross Country Healthcare and gave the stock a buy rating in a report on Wednesday, September 19th. Finally, BMO Capital Markets lowered shares of Cross Country Healthcare from an outperform rating to a market perform rating and set a $13.00 price objective for the company. in a report on Thursday, August 2nd. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company. The stock has an average rating of Hold and an average target price of $12.86.
Cross Country Healthcare (NASDAQ:CCRN) last released its quarterly earnings results on Wednesday, August 1st. The business services provider reported $0.05 EPS for the quarter, missing the Zacks’ consensus estimate of $0.06 by ($0.01). Cross Country Healthcare had a return on equity of 7.90% and a net margin of 4.39%. The company had revenue of $204.57 million during the quarter, compared to analysts’ expectations of $209.29 million. During the same period in the prior year, the firm earned $0.16 EPS. Cross Country Healthcare’s quarterly revenue was down 2.3% on a year-over-year basis. On average, research analysts expect that Cross Country Healthcare will post 0.24 EPS for the current fiscal year.
In other Cross Country Healthcare news, General Counsel Susan E. Ball acquired 5,091 shares of the stock in a transaction dated Thursday, August 9th. The stock was purchased at an average cost of $9.65 per share, for a total transaction of $49,128.15. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Thomas C. Dircks acquired 11,000 shares of the stock in a transaction dated Wednesday, August 8th. The stock was acquired at an average price of $9.07 per share, with a total value of $99,770.00. Following the completion of the acquisition, the director now owns 134,595 shares in the company, valued at approximately $1,220,776.65. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 37,341 shares of company stock valued at $344,203. Company insiders own 3.40% of the company’s stock.
Large investors have recently bought and sold shares of the stock. Koch Industries Inc. bought a new stake in Cross Country Healthcare during the 1st quarter valued at $117,000. Alambic Investment Management L.P. bought a new stake in Cross Country Healthcare during the 2nd quarter valued at $122,000. Aperio Group LLC bought a new stake in Cross Country Healthcare during the 1st quarter valued at $133,000. Barclays PLC raised its holdings in Cross Country Healthcare by 118.6% during the 1st quarter. Barclays PLC now owns 12,283 shares of the business services provider’s stock valued at $136,000 after buying an additional 6,665 shares during the last quarter. Finally, Jane Street Group LLC bought a new stake in Cross Country Healthcare during the 2nd quarter valued at $138,000. Institutional investors own 89.97% of the company’s stock.
About Cross Country Healthcare
Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.
See Also: Outstanding Shares
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.